Brief: Glaukos Q2 Sales USD 95.7 Million Vs. IBES Estimate USD 88.9 Million
31/07/2024 21:05
Jul 31 (Reuters) - Glaukos Q2 adjusted net income USD -26.3 million vs. IBES estimate USD -25.7 million. * Q2 net income USD -53.9 million * Q2 adjusted gross margin 82% * Q2 gross margin 76% * outlook FY sales USD 370-376 million
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary